De Ruyck Pharma SRL
0.3 FTEDe Ruyck Pharma reported total assets of €1.56m at the end of the 2026 financial year (annual accounts filed with the NBB on 02 Nov 2026), with 0.3 full-time equivalent.
The score of De Ruyck Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity +41 % Total assets -5 % Headcount (avg FTE) -62 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
De Ruyck Pharma's annual accounts
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Net result | 47,788 € | ||||
| Equity | 353,696 € | ||||
| Cash | 161,050 € | ||||
| EBITDA | 184,234 € | ||||
| Total assets | €1.56m |
Filed annual accounts
- Year ended 31 Mar 2026filed on 02 Nov 2026
- Year ended 31 Mar 2025filed on 29 Oct 2025
- Year ended 31 Mar 2024filed on 05 Nov 2024
- Year ended 31 Mar 2023filed on 06 Nov 2023
- Year ended 31 Mar 2022filed on 08 Nov 2022
De Ruyck Pharma's financial analysis
- Solvency22.7%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of De Ruyck Pharma
De Ruyck Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0818.535.488
- VAT number
- BE0818535488
- Peppol
- Registered · 0208:0818535488 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 15 Sep 2009
- Registered office
- 9800 Deinze
- Size
- Micro · 0.3 FTE
- Latest accounts
- 2026 · filed on 02 Nov 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
De Ruyck Pharma (SRL) has been based in Deinze since 2009, active in: retail sale of pharmaceutical products. For 2026, it reports a net profit of 47,788 € and equity of 353,696 €; its revenue is not published. With 0.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 22.7%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to De Ruyck Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharma2Care Retail sale of pharmaceutical products Zuienkerke · balance sheet €1.79m
- ELA Services Retail sale of pharmaceutical products Uccle · balance sheet 920,384 €
- Pharmacie Garin Retail sale of pharmaceutical products Jodoigne · balance sheet €1.40m
- Boskant Retail sale of pharmaceutical products Merchtem · balance sheet 729,117 €
- Apotheek Holvoet Retail sale of pharmaceutical products Antwerp · balance sheet 869,040 €
- Humbeek Pharma Retail sale of pharmaceutical products Grimbergen · balance sheet 653,604 €
- ThePharm Retail sale of pharmaceutical products Antwerp · balance sheet 593,897 €
- Inveda Retail sale of pharmaceutical products Ostend · balance sheet €13.6m
Frequently asked questions about De Ruyck Pharma
What is the revenue of De Ruyck Pharma?
De Ruyck Pharma files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of De Ruyck Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0818535488 for De Ruyck Pharma, if the company is VAT-registered. Its company number (CBE) is 0818.535.488.
Where is the registered office of De Ruyck Pharma?
According to the CBE register, the registered office of De Ruyck Pharma is in 9800 Deinze.
What is the equity of De Ruyck Pharma?
At the close of the 2026 financial year, the equity of De Ruyck Pharma amounts to 353,696 €, a solvency of 22.7% of total assets.
How many people work at De Ruyck Pharma?
0.3 full-time equivalents on average according to the 2026 social balance sheet.
Who manages De Ruyck Pharma?
The register lists 2 active mandates at De Ruyck Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of De Ruyck Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →